[HTML][HTML] Lung cancer in females—sex-based differences from males in epidemiology, biology, and outcomes: a narrative review
K Gee, S Yendamuri - Translational Lung Cancer Research, 2024 - ncbi.nlm.nih.gov
Lung cancer in females—sex-based differences from males in epidemiology, biology, and
outcomes: a narrative review - PMC Back to Top Skip to main content NIH NLM Logo Access …
outcomes: a narrative review - PMC Back to Top Skip to main content NIH NLM Logo Access …
18-β-Glycyrrhetinic acid encapsulated PLGA nanoparticles attenuate lung cancer proliferation and migration
KR Paudel, MSB Mohamad, G De Rubis… - Journal of Drug Delivery …, 2024 - Elsevier
Conventional treatment methods to treat lung cancer include radiation therapy,
chemotherapy, and immunotherapy. However, they cause severe adverse effects and …
chemotherapy, and immunotherapy. However, they cause severe adverse effects and …
Cell-Free DNA 5-Hydroxymethylcytosine Signatures for Lung Cancer Prognosis
Accurate prognostic markers are essential for guiding effective lung cancer treatment
strategies. The level of 5-hydroxymethylcytosine (5hmC) in tissue is independently …
strategies. The level of 5-hydroxymethylcytosine (5hmC) in tissue is independently …
[HTML][HTML] Natural Compounds for Preventing Age-Related Diseases and Cancers
MR Ki, S Youn, DH Kim, SP Pack - International Journal of Molecular …, 2024 - mdpi.com
Aging is a multifaceted process influenced by hereditary factors, lifestyle, and environmental
elements. As time progresses, the human body experiences degenerative changes in major …
elements. As time progresses, the human body experiences degenerative changes in major …
Real-world comprehensive genomic and immune profiling reveals distinct age-and sex-based genomic and immune landscapes in tumors of patients with non-small …
Introduction Younger patients with non-small cell lung cancer (NSCLC)(< 50 years)
represent a significant patient population with distinct clinicopathological features and …
represent a significant patient population with distinct clinicopathological features and …
Antiproliferative effect of indeno [1, 2-d] thiazolo [3, 2-a] pyrimidine analogues on IL-6 mediated STAT3 and role of the apoptotic pathway in albino Wistar rats of ethyl …
Lung cancer (LC) ranks second most prevalent cancer in females after breast cancer and
second in males after prostate cancer. Based on the GLOBOCAN 2020 report, India …
second in males after prostate cancer. Based on the GLOBOCAN 2020 report, India …
Quantitative profiling and baseline intervals of trace elements in healthy lung tissues
A Stojsavljević, K Marković, A Lukač… - Journal of Trace …, 2024 - Elsevier
Background Human lung tissue, as an interface with the environment, is susceptible to
various environmental pollutants, including trace metals. However, quantitative data on trace …
various environmental pollutants, including trace metals. However, quantitative data on trace …
The Triterpenoid CDDO-Methyl Ester Reduces Tumor Burden, Reprograms the Immune Microenvironment, and Protects from Chemotherapy-Induced Toxicity in a …
JA Moerland, KT Liby - Antioxidants, 2024 - mdpi.com
NRF2 activation protects epithelial cells from malignancy, but cancer cells can upregulate
the pathway to promote survival. NRF2 activators including CDDO-Methyl ester (CDDO-Me) …
the pathway to promote survival. NRF2 activators including CDDO-Methyl ester (CDDO-Me) …
Outcomes of Multimodal Treatment in Elderly Patients with Localized Non-Small Lung Cancer from a Radiation Oncology Point of View: Special Focus on Low-Dose …
NJ Alt, J Muster, DA Ziegler, S Bendrich, S Donath… - Cancers, 2024 - mdpi.com
Simple Summary Identification of the optimal treatment strategy is challenging in elderly with
non-small cell lung cancer (NSCLC). Outcomes (1) in elderly vs. younger patients and (2) …
non-small cell lung cancer (NSCLC). Outcomes (1) in elderly vs. younger patients and (2) …
EGFR mutation testing, treatment and survival in stage I–III non-small-cell lung cancer: CancerLinQ Discovery database retrospective analysis
B Muthusamy, M Berktas, J Li, DS Thomas, P Sun… - Future …, 2024 - Taylor & Francis
Aim: To describe real-world biomarker testing, treatment and survival in stage IA–IIIC non-
small-cell lung cancer (NSCLC). Methods: Electronic records of USA-based patients in the …
small-cell lung cancer (NSCLC). Methods: Electronic records of USA-based patients in the …